Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | |
| Cash Flows From Operating Activities | |
| Net Income | -38,049 |
| Depreciation Amortization | 146 |
| Other Working Capital | 4,062 |
| Other Operating Activity | 1,681 |
| Operating Cash Flow | $-32,160 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,206 |
| Other Investing Activity | 19,065 |
| Investing Cash Flow | $17,859 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 103,254 |
| Financing Cash Flow | $103,254 |
| Beginning Cash Position | 16,352 |
| End Cash Position | 105,305 |
| Net Cash Flow | $88,953 |
| Free Cash Flow | |
| Operating Cash Flow | -32,160 |
| Free Cash Flow | -32,160 |